New drugs and personalized medicine for multiple sclerosis

被引：0
|
作者：
Paul M. Matthews
机构：
[1] Hammersmith Hospital,Division of Brain Sciences, Department of Medicine
来源：
Nature Reviews Neurology | 2015年 / 11卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The past decade of multiple sclerosis research has been marked by important advances in understanding the disease, a dramatic increase in the range of treatment options and a new spirit of data sharing in research for patient benefit. This progress has made personalized medicine in multiple sclerosis a realistic possibility.
引用
收藏
页码：614 / 616
页数：2
相关论文
共 50 条
  • [1] New drugs and personalized medicine for multiple sclerosis
    Matthews, Paul M.
    [J]. NATURE REVIEWS NEUROLOGY, 2015, 11 (11) : 614 - 616
  • [2] Towards personalized medicine in multiple sclerosis
    Sorensen, P. Soelberg
    [J]. JOURNAL OF NEUROLOGY, 2013, 260 : S8 - S9
  • [3] Personalized medicine in multiple sclerosis: hope or reality?
    Derfuss, Tobias
    [J]. BMC MEDICINE, 2012, 10
  • [4] Translation towards personalized medicine in Multiple Sclerosis
    Miller, Ariel
    Avidan, Nili
    Tzunz-Henig, Noa
    Glass-Marmor, Lea
    Lejbkowicz, Izabella
    Pinter, Ron Y.
    Paperna, Tamar
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2008, 274 (1-2) : 68 - 75
  • [5] Personalized medicine in multiple sclerosis: hope or reality?
    Tobias Derfuss
    [J]. BMC Medicine, 10
  • [6] Pharmacogenetics of multiple sclerosis: personalized therapy with immunomodulatory drugs
    Tsareva, Ekaterina
    Kulakova, Olga
    Boyko, Alexey
    Favorova, Olga
    [J]. PHARMACOGENETICS AND GENOMICS, 2016, 26 (03): : 103 - 115
  • [7] New promising drugs for the treatment of systemic sclerosis: pathogenic considerations, enhanced classifications, and personalized medicine
    Lescoat, Alain
    Varga, John
    Matucci-Cerinic, Marco
    Khanna, Dinesh
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2021, 30 (06) : 635 - 652
  • [8] Pharmacogenetic development of personalized medicine: Multiple sclerosis treatment as a model
    Kirstein-Grossman, I
    Beckmann, JS
    Lancet, D
    Miller, A
    [J]. DRUG NEWS & PERSPECTIVES, 2002, 15 (09) : 558 - 567
  • [9] The elusive biomarker for personalized medicine in multiple sclerosis The search continues
    Rudick, Richard A.
    [J]. NEUROLOGY, 2012, 79 (06) : 498 - 499
  • [10] New drugs for the treatment of multiple sclerosis
    Rio, Jordi
    [J]. REVISTA DE NEUROLOGIA, 2018, 66 (08) : 253 - 253
12345